Products Affected - Description
All presentations are currently available
Reason for the Shortage
- Hospira had verapamil injection on shortage due to increased demand for the product.
- Hospira is the sole supplier of verapamil injection.
Verapamil injection, Hospira
2.5 mg/mL, 2 mL ampule, 5 count (NDC 00409-4011-01)
2.5 mg/mL, 2 mL vial, 25 count (NDC 00409-1144-05)
2.5 mg/mL, 4 mL Ansyr syringe, 5 count (NDC 00409-9633-05)
2.5 mg/mL, 4 mL vial, 5 count (NDC 00409-1144-02)
Estimated Resupply Dates
Hospira has all verapamil presentations available.
January 14, 2016; December 11 and 1, November 9, October 15, September 10, August 11, July 16, June 4, 2015, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins